Related Experiment Videos
Multiple ICAM-1 (CD54) epitopes are involved in homotypic B-cell adhesion
P Bloemen1, G Moldenhauer, M van Dijk
1Department of Clinical Immunology, University Hospital, Utrecht, The Netherlands.
Scandinavian Journal of Immunology
|May 1, 1992
Summary
Two monoclonal antibodies targeting intercellular adhesion molecule 1 (ICAM-1) reveal distinct epitopes involved in human B cell adhesion. These findings highlight ICAM-1
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Homotypic adhesion of human B cells is crucial for immune responses.
- Intercellular Adhesion Molecule 1 (ICAM-1, CD54) plays a role in cell-cell interactions.
- Understanding ICAM-1 epitopes involved in B cell adhesion is essential for therapeutic targeting.
Purpose of the Study:
- To characterize monoclonal antibodies (MoAbs) F10.2 and F10.3 that interfere with human B cell homotypic adhesion.
- To identify the specific epitopes on ICAM-1 recognized by these MoAbs.
- To elucidate the role of different ICAM-1 domains and glycosylation in B cell adhesion.
Main Methods:
- Precipitation studies to determine antibody targets.
- Binding assays using COS cells transfected with ICAM-1 cDNA.
- Inhibition assays with other MoAbs to map epitopes.
- Investigation of glycosylation effects on antibody binding.
Main Results:
- Both MoAbs F10.2 and F10.3 bind to ICAM-1.
- MoAb F10.2 recognizes an epitope on the first domain of ICAM-1.
- MoAb F10.3 recognizes a distinct epitope, potentially on domains 2, 3, or 4, influenced by glycosylation.
- The epitopes recognized by F10.3 and F10.2 (or LB-2) cooperate to mediate homotypic adhesion in ML1 B cells.
Conclusions:
- ICAM-1 homotypic B cell adhesion involves at least two distinct epitopes.
- One epitope is located on the first domain of ICAM-1.
- Another critical epitope's exposure is regulated by glycosylation, suggesting involvement of later domains.